These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Lecithin consumption increases acetylcholine concentrations in rat brain and adrenal gland. Hirsch MJ; Wurtman RJ Science; 1978 Oct; 202(4364):223-5. PubMed ID: 694529 [TBL] [Abstract][Full Text] [Related]
3. Effects of lecithin on EEG and blood levels of choline. Volavka J; Lifshitz K; Friedman E; Sherman KA; Banay-Schwartz M Biol Psychiatry; 1983 Oct; 18(10):1175-9. PubMed ID: 6652158 [No Abstract] [Full Text] [Related]
4. Choline and lecithin in the treatment of tardive dyskinesia: preliminary results from a pilot study. Gelenberg AJ; Doller-Wojcik JC; Growdon JH Am J Psychiatry; 1979 Jun; 136(6):772-6. PubMed ID: 375755 [TBL] [Abstract][Full Text] [Related]
5. Lecithin administration in tardive dyskinesia: clinical and biomedical correlates. Jackson IV; Davis LG; Cohen RK; Nuttall EA Biol Psychiatry; 1981 Jan; 16(1):85-90. PubMed ID: 7225479 [No Abstract] [Full Text] [Related]
6. Neurochemical approaches to the treatment of senile dementia. Growdon JH; Corkin S Proc Annu Meet Am Psychopathol Assoc; 1980; 69():281-96. PubMed ID: 7413654 [No Abstract] [Full Text] [Related]
7. Choline and lecithin administration to patients with tardive dyskinesia. Growdon JH; Gelenberg AJ Trans Am Neurol Assoc; 1978; 103():95-9. PubMed ID: 757093 [No Abstract] [Full Text] [Related]
8. Choline and lecithin for the treatment of tardive dyskinesia [proceedings]. Gelenberg AJ Psychopharmacol Bull; 1979 Apr; 15(2):74-5. PubMed ID: 432384 [No Abstract] [Full Text] [Related]
9. Normal plasma choline responses to ingested lecithin. Zeisel SH; Growdon JH; Wurtman RJ; Magil SG; Logue M Neurology; 1980 Nov; 30(11):1226-9. PubMed ID: 7191517 [TBL] [Abstract][Full Text] [Related]
10. Use of choline and lecithin in the treatment of tardive dyskinesia. Zeisel SH; Gelenberg AJ; Growdon JH; Wurtman RJ Adv Biochem Psychopharmacol; 1980; 24():463-70. PubMed ID: 6996444 [No Abstract] [Full Text] [Related]
11. A dose-ranging study of lecithin in the treatment of primary degenerative dementia (Alzheimer disease). Brinkman SD; Pomara N; Goodnick PJ; Barnett N; Domino EF J Clin Psychopharmacol; 1982 Aug; 2(4):281-5. PubMed ID: 7119136 [No Abstract] [Full Text] [Related]
15. An analysis of dose-response of plasma choline to oral lecithin. Branconnier RJ; Dessain EC; Cole JO; McNiff-Langille ME Biol Psychiatry; 1984 May; 19(5):765-70. PubMed ID: 6733184 [No Abstract] [Full Text] [Related]
16. Fluctuations of free choline levels in plasma of Alzheimer patients receiving lecithin: preliminary observations. Chuaqui P; Levy R Br J Psychiatry; 1982 May; 140():464-9. PubMed ID: 7049290 [TBL] [Abstract][Full Text] [Related]
17. The safety of lecithin diet supplementation in schizophrenic patients. Yackulic CF; Anderson BG; Reker D; Webb E; Volavka J Biol Psychiatry; 1982 Dec; 17(12):1445-8. PubMed ID: 6130801 [No Abstract] [Full Text] [Related]
18. The effect of long-term high dose lecithin on erythrocyte choline transport in Alzheimer patients. Uney JB; Jones GM; Rebeiro A; Levy R Biol Psychiatry; 1992 Mar; 31(6):630-3. PubMed ID: 1581445 [No Abstract] [Full Text] [Related]
19. Effects of consumption of choline and lecithin on neurological and cardiovascular systems. Wood JL; Allison RG Fed Proc; 1982 Dec; 41(14):3015-21. PubMed ID: 6754453 [TBL] [Abstract][Full Text] [Related]
20. Alzheimer disease: lack of effect of lecithin treatment for 3 months. Etienne P; Dastoor D; Gauthier S; Ludwick R; Collier B Neurology; 1981 Dec; 31(12):1552-4. PubMed ID: 7198209 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]